Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Deficiencies”

675 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 675 results

Early research (Phase 1)Active Not RecruitingNCT03283917
What this trial is testing

Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Who this might be right for
Newly Diagnosed Primary AmyloidosisRecurrent Primary AmyloidosisRefractory Primary Amyloidosis
M.D. Anderson Cancer Center 21
Large-scale testing (Phase 3)Study completedNCT03988426
What this trial is testing

Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immune Deficiency Disorder
Octapharma 25
Not applicableLooking for participantsNCT07261891
What this trial is testing

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)
prof. dr. Rik Schrijvers 20
Large-scale testing (Phase 3)Study completedNCT05513586
What this trial is testing

Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 15
Testing effectiveness (Phase 2)Looking for participantsNCT03266653
What this trial is testing

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

Who this might be right for
Epstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Not applicableStudy completedNCT00004694
What this trial is testing

Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations

Who this might be right for
Angioedema
University of Iowa 24
Not applicableStudy completedNCT03335605
What this trial is testing

Improving the Diagnosis of Common Variable Immune Deficiency

Who this might be right for
CVI - Common Variable Immunodeficiency
University of California, Los Angeles 24
Not applicableNot Yet RecruitingNCT07516002
What this trial is testing

Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency

Who this might be right for
Primary Immunodeficiency Diseases
Peking University People's Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT04339777
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Who this might be right for
Lymphoproliferative DisordersAutoimmune LymphoproliferativeImmune System Diseases+2 more
National Cancer Institute (NCI) 66
Not applicableLooking for participantsNCT00246857
What this trial is testing

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

Who this might be right for
Primary Immune Deficiency
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Not applicableUnknownNCT04605523
What this trial is testing

Neurofilament Light- Chain in Ataxia Telangiectasia

Who this might be right for
Ataxia Telangiectasia
Johann Wolfgang Goethe University Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT03538899
What this trial is testing

Autologous Gene Therapy for Artemis-Deficient SCID

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 24
Testing effectiveness (Phase 2)Study completedNCT00782106
What this trial is testing

Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 11
Not applicableAvailableNCT07380165
What this trial is testing

Expanded Access Program (EAP) of Levacetylleucine for Ataxia-Telangiectasia (A-T)

Who this might be right for
Ataxia-Telangiectasia (A-T)
IntraBio Inc
Large-scale testing (Phase 3)Study completedNCT03961009
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 47
Large-scale testing (Phase 3)Study completedNCT00097695
What this trial is testing

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

Who this might be right for
Angioedema
Shire 84
Early research (Phase 1)Study completedNCT00260702
What this trial is testing

Omalizumab to Treat Hyper-IgE (Job's) Syndrome

Who this might be right for
Hyper-IgE SyndromeJob's Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 1
Testing effectiveness (Phase 2)WithdrawnNCT04370795
What this trial is testing

Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus

Who this might be right for
Severe Combined Immune Deficiency (SCID)
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Looking for participantsNCT03266640
What this trial is testing

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Who this might be right for
Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Large-scale testing (Phase 3)Study completedNCT00814320
What this trial is testing

Gammagard Liquid and rHuPH20 in PID

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 89
Load More Results